147 related articles for article (PubMed ID: 31792980)
1. The constitutive activity of melanocortin-4 receptors in cAMP pathway is allosterically modulated by zinc and copper ions.
Link R; Veiksina S; Tahk MJ; Laasfeld T; Paiste P; Kopanchuk S; Rinken A
J Neurochem; 2020 May; 153(3):346-361. PubMed ID: 31792980
[TBL] [Abstract][Full Text] [Related]
2. Metal ion-mediated agonism and agonist enhancement in melanocortin MC1 and MC4 receptors.
Holst B; Elling CE; Schwartz TW
J Biol Chem; 2002 Dec; 277(49):47662-70. PubMed ID: 12244039
[TBL] [Abstract][Full Text] [Related]
3. Homogeneous fluorescence anisotropy-based assay for characterization of ligand binding dynamics to GPCRs in budded baculoviruses: the case of Cy3B-NDP-α-MSH binding to MC4 receptors.
Veiksina S; Kopanchuk S; Mazina O; Link R; Lille A; Rinken A
Methods Mol Biol; 2015; 1272():37-50. PubMed ID: 25563175
[TBL] [Abstract][Full Text] [Related]
4. Fluorescence Anisotropy-Based Assay for Characterization of Ligand Binding Dynamics to GPCRs: The Case of Cy3B-Labeled Ligands Binding to MC
Veiksina S; Tahk MJ; Laasfeld T; Link R; Kopanchuk S; Rinken A
Methods Mol Biol; 2021; 2268():119-136. PubMed ID: 34085265
[TBL] [Abstract][Full Text] [Related]
5. beta-MSH: a functional ligand that regulated energy homeostasis via hypothalamic MC4-R?
Harrold JA; Widdowson PS; Williams G
Peptides; 2003 Mar; 24(3):397-405. PubMed ID: 12732337
[TBL] [Abstract][Full Text] [Related]
6. Budded baculoviruses as a tool for a homogeneous fluorescence anisotropy-based assay of ligand binding to G protein-coupled receptors: the case of melanocortin 4 receptors.
Veiksina S; Kopanchuk S; Rinken A
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):372-81. PubMed ID: 24095674
[TBL] [Abstract][Full Text] [Related]
7. Development of a high throughput screen for allosteric modulators of melanocortin-4 receptor signaling using a real time cAMP assay.
Pantel J; Williams SY; Mi D; Sebag J; Corbin JD; Weaver CD; Cone RD
Eur J Pharmacol; 2011 Jun; 660(1):139-47. PubMed ID: 21296065
[TBL] [Abstract][Full Text] [Related]
8. Agouti-related protein (83-132) is a competitive antagonist at the human melanocortin-4 receptor: no evidence for differential interactions with pro-opiomelanocortin-derived ligands.
Pritchard LE; Armstrong D; Davies N; Oliver RL; Schmitz CA; Brennand JC; Wilkinson GF; White A
J Endocrinol; 2004 Jan; 180(1):183-91. PubMed ID: 14709157
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the melanocortin MC4 receptor in stress-related behavior in rodents.
Chaki S; Ogawa S; Toda Y; Funakoshi T; Okuyama S
Eur J Pharmacol; 2003 Aug; 474(1):95-101. PubMed ID: 12909200
[TBL] [Abstract][Full Text] [Related]
10. Characterization of ligand binding to melanocortin 4 receptors using fluorescent peptides with improved kinetic properties.
Link R; Veiksina S; Rinken A; Kopanchuk S
Eur J Pharmacol; 2017 Mar; 799():58-66. PubMed ID: 28132916
[TBL] [Abstract][Full Text] [Related]
11. Regulation of pigmentation in human epidermal melanocytes by functional high-affinity beta-melanocyte-stimulating hormone/melanocortin-4 receptor signaling.
Spencer JD; Schallreuter KU
Endocrinology; 2009 Mar; 150(3):1250-8. PubMed ID: 18974267
[TBL] [Abstract][Full Text] [Related]
12. Activation of MAP kinase by MC4-R through PI3 kinase.
Vongs A; Lynn NM; Rosenblum CI
Regul Pept; 2004 Aug; 120(1-3):113-8. PubMed ID: 15177928
[TBL] [Abstract][Full Text] [Related]
13. Regulation of endogenous melanocortin-4 receptor expression and signaling by glucocorticoids.
Sebag JA; Hinkle PM
Endocrinology; 2006 Dec; 147(12):5948-55. PubMed ID: 16973723
[TBL] [Abstract][Full Text] [Related]
14. Constitutive activity in melanocortin-4 receptor: biased signaling of inverse agonists.
Tao YX
Adv Pharmacol; 2014; 70():135-54. PubMed ID: 24931195
[TBL] [Abstract][Full Text] [Related]
15. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis of melanocortin-4 receptor for AGRP inverse agonism.
Chen M; Celik A; Georgeson KE; Harmon CM; Yang Y
Regul Pept; 2006 Sep; 136(1-3):40-9. PubMed ID: 16820227
[TBL] [Abstract][Full Text] [Related]
17. Allosteric Inhibition of Serotonin 5-HT
Satała G; Duszyńska B; Lenda T; Nowak G; Bojarski AJ
Mol Neurobiol; 2018 Apr; 55(4):2897-2910. PubMed ID: 28455702
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of agonism and inverse agonism in the melanocortin receptors: Zn(2+) as a structural and functional probe.
Holst B; Schwartz TW
Ann N Y Acad Sci; 2003 Jun; 994():1-11. PubMed ID: 12851292
[TBL] [Abstract][Full Text] [Related]
19. Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation.
Hoare SR; Fleck BA; Gross RS; Crowe PD; Williams JP; Grigoriadis DE
Mol Pharmacol; 2008 May; 73(5):1371-80. PubMed ID: 18239030
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of zinc and copper interaction with the human alpha(1A)-adrenoceptor.
Ciolek J; Maïga A; Marcon E; Servent D; Gilles N
Eur J Pharmacol; 2011 Mar; 655(1-3):1-8. PubMed ID: 21262225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
